ATE126705T1 - Verwendung von lokal zu verabreichendem immunoglobulin zur behandlung epitheler infektionen. - Google Patents

Verwendung von lokal zu verabreichendem immunoglobulin zur behandlung epitheler infektionen.

Info

Publication number
ATE126705T1
ATE126705T1 AT92901306T AT92901306T ATE126705T1 AT E126705 T1 ATE126705 T1 AT E126705T1 AT 92901306 T AT92901306 T AT 92901306T AT 92901306 T AT92901306 T AT 92901306T AT E126705 T1 ATE126705 T1 AT E126705T1
Authority
AT
Austria
Prior art keywords
treatment
infections
epitheral
topically administered
administered immunoglobulin
Prior art date
Application number
AT92901306T
Other languages
English (en)
Inventor
Jean-Michel Alonso
Frederic Courteille
Patrice Binder
Francoise Ramisse
Original Assignee
Fond Nat Transfusion Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9402686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE126705(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fond Nat Transfusion Sanguine filed Critical Fond Nat Transfusion Sanguine
Application granted granted Critical
Publication of ATE126705T1 publication Critical patent/ATE126705T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92901306T 1990-11-28 1991-11-28 Verwendung von lokal zu verabreichendem immunoglobulin zur behandlung epitheler infektionen. ATE126705T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9014881A FR2669538B1 (fr) 1990-11-28 1990-11-28 Utilisation d'immunoglobulines administrees localement dans le traitement des infections epitheliales.

Publications (1)

Publication Number Publication Date
ATE126705T1 true ATE126705T1 (de) 1995-09-15

Family

ID=9402686

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901306T ATE126705T1 (de) 1990-11-28 1991-11-28 Verwendung von lokal zu verabreichendem immunoglobulin zur behandlung epitheler infektionen.

Country Status (5)

Country Link
EP (1) EP0574398B1 (de)
AT (1) ATE126705T1 (de)
DE (1) DE69112428T2 (de)
FR (1) FR2669538B1 (de)
WO (1) WO1992009306A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705032B1 (fr) * 1993-05-11 1995-07-07 France Etat Armement Composition comprenant en combinaison une immunoglobuline et un antigène utilisable en thérapeutique.
IT1278052B1 (it) 1995-03-14 1997-11-17 Mendes Srl Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
AU2315388A (en) * 1987-07-17 1989-02-13 Brigham And Women's Hospital Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections

Also Published As

Publication number Publication date
DE69112428T2 (de) 1996-03-07
EP0574398A1 (de) 1993-12-22
EP0574398B1 (de) 1995-08-23
FR2669538A1 (fr) 1992-05-29
DE69112428D1 (de) 1995-09-28
FR2669538B1 (fr) 1995-03-03
WO1992009306A1 (fr) 1992-06-11

Similar Documents

Publication Publication Date Title
DE69330643D1 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
DE69429095D1 (de) Humanisierte antikoerper
DE69633717D1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
NO976122D0 (no) AntiFasligandantistoffer og analysefremgangsmåte hvor disse anvendes
ES2108120T3 (es) Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf.
ATE162075T1 (de) Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält
ATE245977T1 (de) Therapeutische substituierte guanidine
DK0552296T3 (da) Monoklonale antistoffer fra mus
DE69535319D1 (de) Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten
DK0476226T3 (da) Monoklonalt antistof mod humant IgE
ATE197506T1 (de) Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren
FR2637600B1 (fr) Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
ATE429248T1 (de) Verwendung cd28 spezifischer monoklonaler antikörper zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von virusinfektionen
TR200001265T2 (tr) Vasp' a karşı antikorlar, bunların hazırlanması için hibridoma hücreleri.
KR900700132A (ko) 면역 글로불린 e 반응 억제 방법
DE3162128D1 (en) Biologically active compounds, their obtention from human casein and compositions containing them
MX9301858A (es) Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
ATE300617T1 (de) Fibronektinbindungsprotein, monoklonaler antikoerper und ihre verwendung zur verhuetung der adhäsion von bakterien
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
DE69112428D1 (de) Verwendung von lokal zu verabreichendem Immunoglobulin zur Behandlung epitheler Infektionen.
YU13392A (sh) ANTITELA NA HUMANI RECEPTOR ZA IgE
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
DK1042492T3 (da) Humaniserede monoklonale antistoffer der beskytter med Shiga-toksininducerede sygdomme
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
ES2060695T3 (es) Concentrados terapeuticos de igm.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked